Intra-Cellular Therapies

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

Intra-Cellular Therapies sent this email to their subscribers on December 11, 2024.

December 11, 2024 8:00 AM EST

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

View this release →

Or click here to view all releases.

Text-only version of this email

Intra-Cellular Therapies Inc. December 11, 2024 8:00 AM ESTIntra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting View this release → Or click here to view all releases.

Show all

The Latest Emails Sent By Intra-Cellular Therapies

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

New Form DEFA14A for Intra-Cellular Therapies Inc.

New Form DEFA14A for Intra-Cellular Therapies Inc.

New Form DFAN14A for Intra-Cellular Therapies Inc.

New Form DFAN14A for Intra-Cellular Therapies Inc.

New Form 8-K for Intra-Cellular Therapies Inc.

New Form 8-K for Intra-Cellular Therapies Inc.

New Form DEFA14A for Intra-Cellular Therapies Inc.

New Form DEFA14A for Intra-Cellular Therapies Inc.